WATCHMAN is a one-time procedure that lowers your lifetime risk for stroke if you have AFib (not caused by a heart valve problem) and you have also experienced serious bleeding while on blood thinners ...

The Cottage Heart & Vascular Center’s structural heart team at Santa Barbara Cottage Hospital (SBCH) recently performed their ...

The trial compared the stroke prevention device for left atrial appendage closure to blood thinners in people who underwent ...

The staff at Shasta Regional Medical Center (SRMC) is celebrating their 100th Watchman heart implant procedure, which took ...

Boston Scientific Corp. (BSX) announced positive three-year primary endpoint results from the OPTION global clinical trial of the ...

Boston Scientific announced positive three-year primary endpoint results from a clinical trial of its Watchman FLX device.

Abbott’s Amulet IDE trial put its left atrial appendage closure device up against the Watchman 2.5, which was approved by the ...

(Courtesy photo) The Cottage Heart & Vascular Center’s structural heart team at Santa Barbara Cottage Hospital (SBCH) recently performed their 1,000th WATCHMAN device procedure, a minimally ...

In the trial, approximately 60% of device patients had their WATCHMAN FLX implant 90-180 days following their ablation procedure. The other nearly 40% of the device patients had the two procedures ...